We did not observe increased CD4+ or CD8+ T cell activation at baseline in MIS-C compared with COVID-19 (Supplemental Figure 1B); a finding that may be explained by differences in study populations and/or experimental conditions between our work at that of Vella et al. (8). The gene discussed is CD8A; the disease is COVID-19.